• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[What Is the Optimal Drug Regimen for Eradication Therapy?].

作者信息

Kim Ji Hyun, Park Sung Chul

出版信息

Korean J Helicobacter Up Gastrointest Res. 2024 Jun;24(2):97-99. doi: 10.7704/kjhugr.2024.0022. Epub 2024 Jun 10.

DOI:10.7704/kjhugr.2024.0022
PMID:40502845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11974585/
Abstract
摘要

相似文献

1
[What Is the Optimal Drug Regimen for Eradication Therapy?].根除治疗的最佳药物方案是什么？
Korean J Helicobacter Up Gastrointest Res. 2024 Jun;24(2):97-99. doi: 10.7704/kjhugr.2024.0022. Epub 2024 Jun 10.
2
A Potassium-Competitive Acid Blocker-Based Regimen as Second-Line Therapy Improves Helicobacter pylori Eradication.基于钾离子竞争型酸阻滞剂的二线治疗方案可提高幽门螺杆菌根除率。
Digestion. 2020;101(3):332-338. doi: 10.1159/000499857. Epub 2019 Apr 16.
3
Efficacy of bismuth added to standard triple therapy as the first-line eradication regimen for Helicobacter pylori infection.铋剂四联疗法作为一线方案根除幽门螺杆菌感染的疗效。
Helicobacter. 2021 Jun;26(3):e12792. doi: 10.1111/hel.12792. Epub 2021 Mar 1.
4
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.在临床实践中，基于质子泵抑制剂的三联疗法治疗幽门螺杆菌感染失败时的治疗选择。
Aliment Pharmacol Ther. 1999 Apr;13(4):489-96. doi: 10.1046/j.1365-2036.1999.00504.x.
5
Tailored eradication strategy concomitant therapy for eradication treatment in Korean patients.个体化根除策略联合治疗用于韩国患者的根除治疗。
World J Gastroenterol. 2021 Aug 21;27(31):5247-5258. doi: 10.3748/wjg.v27.i31.5247.
6
Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study.基于 vonoprazan 的方案治疗日本青少年幽门螺杆菌根除治疗的疗效和安全性：一项前瞻性多中心研究。
J Gastroenterol. 2023 Mar;58(3):196-204. doi: 10.1007/s00535-022-01942-z. Epub 2022 Dec 17.
7
Helicobacter pylori eradication with dual and low-dose triple therapy in patients with liver cirrhosis.肝硬化患者采用双重和低剂量三联疗法根除幽门螺杆菌
Ital J Gastroenterol Hepatol. 1999 Dec;31(9):831-5.
8
Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review.根治性治疗对接受血液透析患者幽门螺杆菌感染的影响：综述。
Helicobacter. 2024 May-Jun;29(3):e13106. doi: 10.1111/hel.13106.
9
Investigating the Efficacy of Triple Drug Therapy and Sequential Drug Therapy in the Eradication of Helicobacter Pylori with Respect to Antigen Stool test: A Pilot Study.探讨三联药物疗法和序贯药物疗法根除幽门螺杆菌对粪便抗原检测的疗效：一项初步研究。
Kathmandu Univ Med J (KUMJ). 2020;18(69):74-83.
10
Eradication rate and safety of a "simplified rescue therapy": 14-day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real-world, retrospective clinical study in China.简化挽救治疗的根除率和安全性：14 天 vonoprazan 和阿莫西林双联方案作为补救治疗，用于治疗中国既往治疗失败的幽门螺杆菌感染：一项真实世界、回顾性临床研究。
Helicobacter. 2022 Oct;27(5):e12918. doi: 10.1111/hel.12918. Epub 2022 Jul 25.

引用本文的文献

1
Practical Efficacy of a 1-Week Metronidazole-Based Triple Regimen Plus Bismuth Versus a 2-Week Bismuth-Based Quadruple Regimen for Helicobacter pylori Infection With Clarithromycin-Resistance-Associated Genetic Mutations.基于甲硝唑的一周三联疗法加铋剂与基于铋剂的两周四联疗法治疗伴有克拉霉素耐药相关基因突变的幽门螺杆菌感染的实际疗效比较
Korean J Helicobacter Up Gastrointest Res. 2025 Sep;25(3):261-267. doi: 10.7704/kjhugr.2025.0022. Epub 2025 Sep 1.

本文引用的文献

1
Efficacy of tegoprazan-based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double-blind, active-controlled study.替戈拉赞铋剂四联疗法对比铋剂四联疗法治疗幽门螺杆菌感染的疗效：一项随机、双盲、阳性对照研究。
Helicobacter. 2023 Jun;28(3):e12977. doi: 10.1111/hel.12977. Epub 2023 Apr 21.
2
Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Eradication.基于替戈拉赞的14天三联疗法与基于替戈拉赞的10天联合疗法根除幽门螺杆菌的疗效比较
J Pers Med. 2022 Nov 17;12(11):1918. doi: 10.3390/jpm12111918.
3
7-day versus 14-day tegoprazan-based triple therapy to treat Helicobacter pylori infection: Real-world evidence.7 天与 14 天替戈拉赞三联疗法治疗幽门螺杆菌感染：真实世界证据。
J Gastroenterol Hepatol. 2022 Oct;37(10):1911-1918. doi: 10.1111/jgh.15939. Epub 2022 Jul 19.
4
Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Infection: A Randomized, Double-Blind, Phase III, Clinical Trial.基于新型钾离子竞争性酸阻滞剂替戈拉赞的三联疗法用于一线治疗感染：一项随机、双盲、III 期临床试验。
Gut Liver. 2022 Jul 15;16(4):535-546. doi: 10.5009/gnl220055. Epub 2022 Jul 6.
5
Evidence-Based Guidelines for the Treatment of Infection in Korea 2020.2020 年韩国感染治疗循证指南。
Gut Liver. 2021 Mar 15;15(2):168-195. doi: 10.5009/gnl20288.
6
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Infection: A Nationwide Randomized Trial in Korea.十日伴随疗法、十日序贯疗法与七日三联疗法作为一线治疗方案用于 感染：韩国全国范围内的一项随机试验
Gut Liver. 2019 Sep 15;13(5):531-540. doi: 10.5009/gnl19136.
7
Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for Eradication: A Meta-Analysis of Randomized Clinical Trials.基于 vonoprazan 的三联疗法与质子泵抑制剂三联疗法根除疗效和安全性的 Meta 分析：随机临床试验。
Biomed Res Int. 2019 May 9;2019:9781212. doi: 10.1155/2019/9781212. eCollection 2019.
8
Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.韩国全国范围内幽门螺杆菌抗生素耐药性的绘图：一项前瞻性多中心研究。
Helicobacter. 2019 Aug;24(4):e12592. doi: 10.1111/hel.12592. Epub 2019 May 20.
9
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.系统评价与荟萃分析：强效酸抑制剂——沃诺拉赞优于质子泵抑制剂，可根除克拉霉素耐药的幽门螺杆菌菌株。
Helicobacter. 2018 Aug;23(4):e12495. doi: 10.1111/hel.12495. Epub 2018 Jun 6.
10
Concomitant or Sequential Therapy as the First-line Therapy for Eradication of Infection in Korea: A Systematic Review and Meta-analysis.韩国根除感染的一线治疗中序贯或序贯疗法：一项系统评价和荟萃分析。
Korean J Gastroenterol. 2018 Jan 25;71(1):31-37. doi: 10.4166/kjg.2018.71.1.31.